SAN FRANCISCO - The outlook for the gene therapy industry appears to be positive for the coming year, according to a Monday presentation in the Biotech Showcase, part of this week's J.P. Morgan Healthcare Conference. In a separate talk, presenters discussed the "booming" biotech industry and whether the sector's frenetic growth could be a sign of looming turbulence.
